BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28350791)

  • 21. Use of proton pump inhibitors for the risk of gastric cancer.
    Gao H; Li L; Geng K; Teng C; Chen Y; Chu F; Zhao Y
    Medicine (Baltimore); 2022 Dec; 101(49):e32228. PubMed ID: 36626449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exposure to acid-suppressing drugs during pregnancy and the risk of asthma in childhood: an observational cohort study.
    Cea Soriano L; Hernández-Díaz S; Johansson S; Nagy P; García-Rodríguez LA
    Aliment Pharmacol Ther; 2016 Feb; 43(3):427-37. PubMed ID: 26612701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drugs for peptic ulcer disease and GERD.
    Treat Guidel Med Lett; 2011 Sep; 9(109):55-60; quiz 2 p following 60. PubMed ID: 21860368
    [No Abstract]   [Full Text] [Related]  

  • 24. [Adverse effects of drugs for peptic ulcer diseases].
    Haruma K; Kamada T; Shiotani A
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():266-71. PubMed ID: 23156519
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms.
    Ko Y; Tang J; Sanagapalli S; Kim BS; Leong RW
    Expert Opin Drug Saf; 2016 Jan; 15(1):53-63. PubMed ID: 26560097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histamine H2-Blocker and Proton Pump Inhibitor Use and the Risk of Pneumonia in Acute Stroke: A Retrospective Analysis on Susceptible Patients.
    Arai N; Nakamizo T; Ihara H; Koide T; Nakamura A; Tabuse M; Miyazaki H
    PLoS One; 2017; 12(1):e0169300. PubMed ID: 28085910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in patients' symptoms and gastric emptying after Helicobacter pylori treatment.
    Zhang CL; Geng CH; Yang ZW; Li YL; Tong LQ; Gao P; Gao YQ
    World J Gastroenterol; 2016 May; 22(18):4585-93. PubMed ID: 27182168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton Pump Inhibitor Use and Obesity-Associated Cancer in the Women's Health Initiative.
    Ballinger TJ; Djuric Z; Sardesai S; Hovey KM; Andrews CA; Brasky TM; Zhang JT; Rohan TE; Saquib N; Shadyab AH; Simon M; Wactawski-Wende J; Wallace R; Kato I
    Nutr Cancer; 2023; 75(1):265-275. PubMed ID: 35968582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.
    MacLaren R; Kassel LE; Kiser TH; Fish DN
    Expert Opin Drug Saf; 2015 Feb; 14(2):269-80. PubMed ID: 25423448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acid-suppressive medications and risk of colorectal cancer: results from three large prospective cohort studies.
    Babic A; Zhang X; Morales-Oyarvide V; Yuan C; Khalaf N; Khalili H; Lochhead P; Chan AT; Ogino S; Wolpin BM; Wu K; Fuchs CS; Giovannucci EL; Stampfer MJ; Ng K
    Br J Cancer; 2020 Sep; 123(5):844-851. PubMed ID: 32541871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adverse effects of gastric acid suppressive drugs].
    Haruma K; Kamada T; Shiotani A
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():198-201. PubMed ID: 18074539
    [No Abstract]   [Full Text] [Related]  

  • 32. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication.
    Shichijo S; Hirata Y; Niikura R; Hayakawa Y; Yamada A; Ushiku T; Fukayama M; Koike K
    Gastrointest Endosc; 2016 Oct; 84(4):618-24. PubMed ID: 26995689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acid-Suppressing Agents and Risk for Clostridium difficile Infection in Pediatric Patients.
    Brown KE; Knoderer CA; Nichols KR; Crumby AS
    Clin Pediatr (Phila); 2015 Oct; 54(11):1102-6. PubMed ID: 25644650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
    Landi SN; Sandler RS; Pate V; Lund JL
    Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of gastric acid secretion in health and disease.
    Schubert ML; Peura DA
    Gastroenterology; 2008 Jun; 134(7):1842-60. PubMed ID: 18474247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori.
    Hagiwara T; Mukaisho K; Nakayama T; Sugihara H; Hattori T
    Gut; 2011 May; 60(5):624-30. PubMed ID: 21097844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitors and risk of gastric cancer: population-based cohort study.
    Abrahami D; McDonald EG; Schnitzer ME; Barkun AN; Suissa S; Azoulay L
    Gut; 2022 Jan; 71(1):16-24. PubMed ID: 34226290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients.
    Yoshihisa A; Takiguchi M; Kanno Y; Sato A; Yokokawa T; Miura S; Abe S; Misaka T; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer.
    Cho SJ; Choi IJ; Kook MC; Yoon H; Park S; Kim CG; Lee JY; Lee JH; Ryu KW; Kim YW
    Aliment Pharmacol Ther; 2013 Sep; 38(5):477-89. PubMed ID: 23822578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From nerves and hormones to bacteria in the stomach; Nobel prize for achievements in gastrology during last century.
    Konturek SJ; Konturek PC; Brzozowski T; Konturek JW; Pawlik WW
    J Physiol Pharmacol; 2005 Dec; 56(4):507-30. PubMed ID: 16391411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.